Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13835
Country/Region: Uganda
Year: 2016
Main Partner: Baylor College of Medicine
Main Partner Program: Children's Foundation
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $14,231,103 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,807,401
Care: Orphans and Vulnerable Children (HKID) $1,209,415
Care: TB/HIV (HVTB) $488,743
Care: Pediatric Care and Support (PDCS) $1,428,196
Laboratory Infrastructure (HLAB) $55,700
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,349,862
Testing: HIV Testing and Counseling (HVCT) $1,503,142
Sexual Prevention: Other Sexual Prevention (HVOP) $702,131
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $683,753
Treatment: Adult Treatment (HTXS) $4,266,420
Treatment: Pediatric Treatment (PDTX) $736,340
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 81
GEND_GBV Age/Sex: <10 Female 2017 217
GEND_GBV Age/Sex: <10 Male 2017 133
GEND_GBV Age/Sex: <10 Male 2017 46
GEND_GBV Age/Sex: 10-14 Female 2017 216
GEND_GBV Age/Sex: 10-14 Female 2017 601
GEND_GBV Age/Sex: 10-14 Male 2017 133
GEND_GBV Age/Sex: 10-14 Male 2017 46
GEND_GBV Age/Sex: 15-19 Female 2017 387
GEND_GBV Age/Sex: 15-19 Female 2017 1,080
GEND_GBV Age/Sex: 15-19 Male 2017 76
GEND_GBV Age/Sex: 15-19 male 2017 224
GEND_GBV Age/Sex: 20-24 Female 2017 373
GEND_GBV Age/Sex: 20-24 Female 2017 1,052
GEND_GBV Age/Sex: 20-24 Male 2017 217
GEND_GBV Age/Sex: 20-24 Male 2017 81
GEND_GBV Age/Sex: 25-49 Female 2017 155
GEND_GBV Age/Sex: 25-49 Female 2017 438
GEND_GBV Age/Sex: 25-49 Male 2017 217
GEND_GBV Age/Sex: 25-49 Male 2017 81
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 140
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 390
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 339
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 953
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,203
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 3,359
GEND_GBV Number of people receiving post-GBV care 2017 4,312
GEND_GBV Number of people receiving post-GBV care 2017 1,542
GEND_GBV Sum of Age/Sex Disaggregates 2017 389
GEND_GBV Sum of Age/Sex Disaggregates 2017 1,084
HTS_TST Age/sex: <1 2017 956
HTS_TST Age/sex: <1 2017 3,174
HTS_TST Age/sex: 1-9 2017 3,151
HTS_TST Age/sex: 1-9 2017 10,448
HTS_TST Age/sex: 10-14 Female 2017 2,719
HTS_TST Age/sex: 10-14 Female 2017 9,023
HTS_TST Age/sex: 10-14 Male 2017 2,711
HTS_TST Age/sex: 10-14 Male 2017 9,004
HTS_TST Age/sex: 15-19 Female 2017 17,256
HTS_TST Age/sex: 15-19 Female 2017 50,077
HTS_TST Age/sex: 15-19 Male 2017 14,605
HTS_TST Age/sex: 15-19 Male 2017 52,276
HTS_TST Age/sex: 20-24 Female 2017 25,889
HTS_TST Age/sex: 20-24 Female 2017 75,124
HTS_TST Age/sex: 20-24 Male 2017 21,914
HTS_TST Age/sex: 20-24 Male 2017 78,425
HTS_TST Age/sex: 25-49 Female 2017 39,688
HTS_TST Age/sex: 25-49 Female 2017 115,181
HTS_TST Age/sex: 25-49 Male 2017 33,595
HTS_TST Age/sex: 25-49 Male 2017 120,242
HTS_TST Age/sex: 50+ Female 2017 3,449
HTS_TST Age/sex: 50+ Female 2017 10,006
HTS_TST Age/sex: 50+ Male 2017 2,909
HTS_TST Age/sex: 50+ Male 2017 10,459
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,777
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 15,837
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,760
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 15,812
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 86,282
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 250,388
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 73,023
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 261,402
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 168,842
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 543,439
HTS_TST Service Delivery Point (Facility): Index testing 2017 12,015
HTS_TST Service Delivery Point (Facility): Index testing 2017 31,954
HTS_TST Service Delivery Point (Facility): Inpatient 2017 28,667
HTS_TST Service Delivery Point (Facility): Inpatient 2017 94,036
HTS_TST Service Delivery Point (Facility): Other PITC 2017 11,024
HTS_TST Service Delivery Point (Facility): Other PITC 2017 32,321
HTS_TST Service Delivery Point (Facility): Outpatient 2017 80,919
HTS_TST Service Delivery Point (Facility): Outpatient 2017 231,375
HTS_TST Service Delivery Point (Facility): Pediatric 2017 8,058
HTS_TST Service Delivery Point (Facility): Pediatric 2017 28,084
HTS_TST Service Delivery Point (Facility): PMTCT 2017 27,206
HTS_TST Service Delivery Point (Facility): PMTCT 2017 75,958
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 953
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 3,030
HTS_TST Service Delivery Point (Facility): VMMC 2017 46,681
HTS_TST Sum of Age/Sex disaggregates 2017 164,735
HTS_TST Sum of Age/Sex disaggregates 2017 529,817
HTS_TST Sum of Aggregated Age/Sex <15 2017 9,537
HTS_TST Sum of Aggregated Age/Sex <15 2017 31,649
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 159,305
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 511,790
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 168,842
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 543,439
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 97
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 324
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 89
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 307
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 639
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,779
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 395
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 1,257
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 964
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2,669
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 593
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,886
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,475
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 4,090
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 908
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 2,892
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 123
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 355
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 77
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 247
HTS_TST_POS Test Result by Age: Positive: <1 2017 27
HTS_TST_POS Test Result by Age: Positive: <1 2017 103
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 107
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 365
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 167
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 565
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 153
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 534
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3,201
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 8,893
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,973
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 6,282
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,209
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,209
KP_PREV Total estimated number of key population in the catchment area 2017 5,022
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 5,022
OVC_SERV Age/Sex: 18+ Female 2017 2,766
OVC_SERV Age/Sex: 18+ Male 2017 2,284
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 7,892
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 7,389
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 20,331
OVC_SERV Sum of Age/Sex disaggregates 2017 5,050
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,034
PMTCT_ART Already on ART at beginning of current pregnancy 2017 3,047
PMTCT_ART New on ART 2017 748
PMTCT_ART New on ART 2017 2,194
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 27,498
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 86,662
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,178
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,464
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 329
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 965
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 11
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 41
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 57
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 173
PMTCT_EID Sum of Infant Age disaggregates 2017 1,507
PMTCT_EID Sum of Infant Age disaggregates 2017 4,429
PMTCT_STAT By: Known positives at entry 2017 1,097
PMTCT_STAT By: Known positives at entry 2017 3,246
PMTCT_STAT By: Number of new positives identified 2017 784
PMTCT_STAT By: Number of new positives identified 2017 2,284
PMTCT_STAT Number of new ANC and L&D clients 2017 28,197
PMTCT_STAT Number of new ANC and L&D clients 2017 88,887
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 27,498
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 86,662
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,881
PMTCT_STAT Sum of Positives Status disaggregates 2017 5,530
PP_PREV Aggregated Age/sex: <15 Female 2017 8,497
PP_PREV Aggregated Age/sex: <15 Male 2017 7,845
PP_PREV Aggregated Age/sex: 15+ Female 2017 9,978
PP_PREV Aggregated Age/sex: 15+ Male 2017 10,007
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 36,328
PP_PREV Total number of people in the target population 2017 166,564
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 18
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 150
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 38
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 318
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 56
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 471
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 56
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 471
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 5,643
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,013
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 101
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 557
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 304
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,698
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 608
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,388
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,413
TB_SCREENDX Screen Results: Screened Positive for TB 2017 252
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 494
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 435
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 7,748
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 40,436
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 3,993
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 20,821
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 4,909
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 4,357
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 12,670
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 70,523
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 46
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 74
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 698
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 8
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 65
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 137
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,254
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 222
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,063
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 222
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,063
TX_CURR Age/Sex: <1 2017 34
TX_CURR Age/Sex: <1 2017 363
TX_CURR Age/Sex: <1-9 2017 2,223
TX_CURR Age/Sex: 1-9 2017 229
TX_CURR Age/Sex: 10-14 Female 2017 357
TX_CURR Age/Sex: 10-14 Female 2017 3,584
TX_CURR Age/Sex: 10-14 Male 2017 309
TX_CURR Age/Sex: 10-14 Male 2017 3,096
TX_CURR Age/Sex: 15-19 Female 2017 389
TX_CURR Age/Sex: 15-19 Female 2017 2,023
TX_CURR Age/Sex: 15-19 Male 2017 117
TX_CURR Age/Sex: 15-19 Male 2017 623
TX_CURR Age/Sex: 20-24 Female 2017 1,783
TX_CURR Age/Sex: 20-24 Female 2017 9,300
TX_CURR Age/Sex: 20-24 Male 2017 798
TX_CURR Age/Sex: 20-24 Male 2017 4,163
TX_CURR Age/Sex: 25-49 Female 2017 5,187
TX_CURR Age/Sex: 25-49 Female 2017 27,090
TX_CURR Age/Sex: 25-49 Male 2017 2,875
TX_CURR Age/Sex: 25-49 Male 2017 14,995
TX_CURR Age/Sex: 50+ Female 2017 389
TX_CURR Age/Sex: 50+ Female 2017 2,023
TX_CURR Age/Sex: 50+ Male 2017 203
TX_CURR Age/Sex: 50+ Male 2017 1,040
TX_CURR Aggregated Age/Sex: <15 Female 2017 494
TX_CURR Aggregated Age/Sex: <15 Female 2017 4,909
TX_CURR Aggregated Age/Sex: <15 Male 2017 435
TX_CURR Aggregated Age/Sex: <15 Male 2017 4,357
TX_CURR Aggregated Age/Sex: 15+ Female 2017 7,748
TX_CURR Aggregated Age/Sex: 15+ Female 2017 40,436
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,993
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,821
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 12,670
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 70,523
TX_CURR Sum of age/sex disaggregates 2017 2,646
TX_CURR Sum of Age/Sex disaggregations 2017 506
TX_CURR Sum of Aggregated Age/Sex <15 2017 929
TX_CURR Sum of Aggregated Age/Sex <15 2017 9,266
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 11,741
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 61,257
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 12,670
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 70,523
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 113
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 628
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 88
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 548
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,570
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 13,881
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,838
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 7,151
TX_NEW By Age/Sex: <1 2017 35
TX_NEW By Age/Sex: 1-9 2017 49
TX_NEW By Age/Sex: 1-9 2017 287
TX_NEW By Age/Sex: 10-14 Female 2017 90
TX_NEW By Age/Sex: 10-14 Female 2017 465
TX_NEW By Age/Sex: 10-14 Male 2017 62
TX_NEW By Age/Sex: 10-14 Male 2017 389
TX_NEW By Age/Sex: 15-19 Female 2017 176
TX_NEW By Age/Sex: 15-19 Female 2017 695
TX_NEW By Age/Sex: 15-19 Male 2017 51
TX_NEW By Age/Sex: 15-19 Male 2017 211
TX_NEW By Age/Sex: 20-24 Female 2017 821
TX_NEW By Age/Sex: 20-24 Female 2017 3,196
TX_NEW By Age/Sex: 20-24 Male 2017 366
TX_NEW By Age/Sex: 20-24 Male 2017 1,423
TX_NEW By Age/Sex: 25-49 Female 2017 2,392
TX_NEW By Age/Sex: 25-49 Female 2017 9,299
TX_NEW By Age/Sex: 25-49 Male 2017 1,323
TX_NEW By Age/Sex: 25-49 Male 2017 5,148
TX_NEW By Age/Sex: 50+ Female 2017 181
TX_NEW By Age/Sex: 50+ Female 2017 691
TX_NEW By Age/Sex: 50+ Male 2017 98
TX_NEW By Age/Sex: 50+ Male 2017 369
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 5,609
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 22,208
TX_NEW Sum of Age/Sex disaggregates 2017 5,560
TX_NEW Sum of Age/Sex disaggregates 2017 21,886
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 5,609
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 22,208
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 10,135
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 56,420
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 9,123
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 50,778
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 356
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 3,534
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 313
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 3,140
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 5,577
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 29,104
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,877
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 15,000
TX_PVLS Numerator: Indication: Routine 2017 9,123
TX_PVLS Numerator: Indication: Routine 2017 50,778
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 399
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 3,930
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 350
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 3,488
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 6,196
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 32,342
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 3,190
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 16,660
TX_PVLS_den Denominator: Indication: Routine 2017 10,135
TX_PVLS_den Denominator: Indication: Routine 2017 56,420
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 122
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 35
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 190
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 206
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 188
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 33
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 236
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 125
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 875
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 42
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 375
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,549
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 886
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,693
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 189
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 309
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,936
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 36
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 241
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 42
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 286
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 556
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,801
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,229
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7,907
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,863
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 12,235
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,093
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 13,748
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 136
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 35
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 209
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 29
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 224
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 31
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 212
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 39
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 264
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 987
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 276
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,773
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 421
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,867
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 991
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,395
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 43
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 220
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 72
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 449
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 36
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 266
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 42
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 315
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 637
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,286
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,378
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,881
VMMC_CIRC By Age: 10-14 2017 18,206
VMMC_CIRC By Age: 15-19 2017 13,537
VMMC_CIRC By Age: 20-24 2017 6,536
VMMC_CIRC By Age: 25-29 2017 3,735
VMMC_CIRC By Age: 30-49 2017 3,735
VMMC_CIRC By Age: 50+ 2017 932
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 46,681
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 46,681
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 46,681
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 39,211
Cross Cutting Budget Categories and Known Amounts Total: $300,000
Gender: Gender Based Violence (GBV) $300,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Capacity building
Monitoring and Evaluation